
Argenx Euronext brussels
Argenx SE (ARGX) is a global biotechnology company headquartered in Amsterdam, Netherlands. The company focuses on the research, development and commercialization of antibody-based therapies for autoimmune diseases. Its products are essential for targeted modulation of the immune system across neuromuscular and hematologic conditions, including efgartigimod therapies such as Vyvgart and Vyvgart Hytrulo and a pipeline of candidates addressing FcRn and other immune pathways. The company plays a major role in the global biotechnology sector and broader markets.
Start trading
Argenx now
At In2Markets, we offer unique strategies designed to align with your goals and adapt to changing market conditions. Our team will provide you with real-time support and expert insights to answer your question in a quick and personal way. Whether you’re trading or managing your portfolio, we combine innovation with a personalized approach to ensure you stay ahead.
